Delivery Order SPE2DB25D3201-SPE2DB25FNVXK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Feraheme 510 mg/17 mL vials valued at $2,749.40. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and represents performance to be fulfilled at the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Feraheme 510 mg/17 mL vials. This non-set-aside, competitively awarded contract carries a ceiling value of $1,545.64 with firm fixed pricing and an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location. This delivery...
- This federal contract award, valued at $2,000.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Feraheme 510 mg/17 ml vials. The contract is a Firm Fixed Price Delivery Order with a performance period extending through April 30, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global...
- This federal contract award, valued at $2,292.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Feraheme, a 510 mg/17 ml vial used for medical treatments. The contract is a firm-fixed-price delivery order with a performance period extending through May 2, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $25,193.87, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Feraheme 510 mg/17 ml vials, a pharmaceutical product used in medical treatment. The contract is a Delivery Order issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Feraheme, a 510(mg)/17(mL) vial medication, with a ceiling value of $16,862.17 and a performance period extending to June 12, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,218.10 firm fixed-price delivery order is for the supply of 4557621858 FERAHEME 510 MG/17 ML VIAL 17ML, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Feraheme, a 510 mg/17 ml vial medication, with a ceiling value of $11,000.22 and a completion date of July 8, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Feraheme 510 mg/17 ml vials. The contract has a firm fixed-price structure and a ceiling value of $9,635.91. It was awarded on November 4, 2024, with an ultimate completion date of November 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,430.82 Firm Fixed Price Delivery Order is for the product "FERAHEME 510 MG/17 ML VIAL 17ML" and has a completion date of July 8, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- SPE2DB25D3201Indefinite Delivery Contract
- SPE2DB25D3201-SPE2DB25FNVXKDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,374.70 for Feraheme 510 mg/17 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This non-set-aside award utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's defense and veteran healthcare systems. As a major pharmaceutical distributor, the company fulfills diverse medical procurement needs across the DLA's Medical Supply Chain, providing branded and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. The firm fixed price delivery order mechanism allows DLA to procure specific pharmaceutical products on an as-needed basis under the overarching IDC vehicle, demonstrating the efficiency of the indefinite delivery contract structure for routine medical supply replenishment.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/25/25 |